Seoulin Bioscience Market Cap

Seoulin Bioscience has a market cap or net worth of 56.23 billion as of March 9, 2026. Its market cap has decreased by -3.12% in one year.

Market Cap

56.23B

Enterprise Value

36.47B

Revenue

76.74B

Ranking

n/a

PE Ratio

28.62

Stock Price

6,370.00

Market Cap Chart

Since October 25, 2005, Seoulin Bioscience's market cap has decreased from 69.74B to 56.23B, a decrease of -19.38%. That is a compound annual growth rate of -1.05%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	56.23B	-2.15%
Dec 30, 2025	57.46B	-6.51%
Dec 30, 2024	61.46B	-21.97%
Dec 28, 2023	78.77B	-19.25%
Dec 29, 2022	97.55B	-44.18%
Dec 30, 2021	174.75B	62.58%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Protia	63.87B
GeneMatrix	45.27B
Green Cross Medical Science	79.03B
HLB Panagene	92.99B
Cytogen	107.04B
GENINUS	140.91B
Median Diagnostics	17.12B
PeopleBio	16.00B

Market Cap Rankings